Image

Transgender and Gender-Diverse Breast Cancer Screening Pilot

Recruiting
30 years of age
Both
Phase N/A

Powered by AI

Overview

This investigation is a prospective breast cancer screening study open to all transgender and gender-diverse persons (regardless of sex assigned at birth). Using a mixed methods approach, the study will 1) gather prospective quantitative breast imaging data in conjunction with gender-affirming therapy and family cancer history and 2) investigate TGD persons perceptions and experiences in the breast cancer screening program, and 3) identify individual and systems-level barriers to breast cancer screening.

Eligibility

Inclusion Criteria for Transfeminine/Nonbinary/Gender-Diverse Persons:

  1. Assigned male or intersex at birth and do not identify as cisgender
  2. Age:
    1. 40-75 years
    2. 35-39 years with a family history of breast cancer, defined as ≥1 1st or 2nd degree relative(s) with a breast cancer diagnosis
    3. 30-34 with a 1st degree relative with a breast cancer diagnosis age ≤45
  3. A history of gender-affirming hormone therapy ≥9 months.
  4. Ability to speak, read, and write in English.
  5. Ability to understand a written informed consent document, and the willingness to sign it.

Inclusion Criteria for Transmasculine/Nonbinary/Gender-Diverse Persons:

  1. Assigned female or intersex at birth and do not identify as cisgender
  2. Age:
    1. 40-75 years
    2. 35-39 years with a family history of breast cancer, defined as ≥1 1st or 2nd degree relative(s) with a breast cancer diagnosis
    3. 30-34 years with a 1st degree relative with a breast cancer diagnosis age ≤45
  3. Any history of gender-affirming hormone therapy, regardless of duration.
  4. Has not undergone a complete mastectomy for oncologic or risk-reducing reasons. (Note: those who have undergone top surgery are eligible, assuming they meet this criterion).
  5. Ability to speak, read, and write in English.
  6. Ability to understand a written informed consent document, and the willingness to sign it.

Inclusion Criteria for Breast Radiology Faculty:

  1. Board-certified radiologist that specializes in breast imaging and are an actively employed faculty member at Froedtert & the Medical College of Wisconsin (main campus location).
  2. Part of the breast radiology faculty who read both ABUS and MMG of the TGD study participants.
  3. Ability to speak, read, and write in English.
  4. Ability to understand a written informed consent document, and the willingness to sign it.

Inclusion Criteria for Breast Radiology Staff:

  1. Must be either a technician, nurse, or clerical staff that works with the breast radiology team at Froedtert & the Medical College of Wisconsin (main campus location).
  2. Ability to understand a written informed consent document, and the willingness to sign it.
  3. Ability to speak, read, and write in English.

Exclusion Criteria for Transfeminine/Nonbinary/Gender-Diverse Persons

  1. Has a history of breast cancer.
  2. Has a known pathogenic gene mutation that increases the risk of breast cancer development (e.g., BRCA1/2).
  3. Has not been on GAHT for ≥ 9 months.

Exclusion Criteria for Transmasculine/Nonbinary/Gender-Diverse Persons

  1. Has undergone or planned to undergo a complete mastectomy.
  2. Has a history of breast cancer.
  3. Has a known pathogenic gene mutation that increases the risk of breast cancer development (e.g., BRCA1/2).

Exclusion Criteria for Breast Radiology Faculty

  1. Not a board-certified radiologist.
  2. Does not specialize in breast imaging.
  3. Does not read ABUS and MMG and/or has not read imaging for study participants.

Exclusion for Breast Radiology Staff

  1. Does not work with the breast radiology team.

Study details

Breast Cancer

NCT06383026

Medical College of Wisconsin

4 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.